Michael J. Haller

Pediatrics
1505 SW Archer Rd
Gainesville, FL 32608

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 197 publications

Please Tell Me It Is Only a Nightmare-The Proposed Dismantling of the United States Federal Research Infrastructure.

Please Tell Me It Is Only a Nightmare-The Proposed Dismantling of the United States Federal Research Infrastructure.

Journal: Diabetes care
Published: June 08, 2026

Inhaled Technosphere Insulin Reduces Postmeal Glucose Excursion in Youth Living with Type 1 Diabetes.

Inhaled Technosphere Insulin Reduces Postmeal Glucose Excursion in Youth Living with Type 1 Diabetes.

Journal: Diabetes technology & therapeutics
Published: March 14, 2026

Identification of a type 1 diabetes-associated T cell receptor repertoire signature from the human peripheral blood.

Identification of a type 1 diabetes-associated T cell receptor repertoire signature from the human peripheral blood.

Journal: Science advances
Published: February 13, 2026

Inhaled Technosphere Insulin in Children with Diabetes: The INHALE-1 Extension Study.

Inhaled Technosphere Insulin in Children with Diabetes: The INHALE-1 Extension Study.

Journal: Diabetes technology & therapeutics
Published: February 05, 2026

Low-Dose Antithymocyte Globulin in Type 1 Diabetes: Real-World Exploratory Observation of C-Peptide by Modified Quantitative Response (mQR).

Low-Dose Antithymocyte Globulin in Type 1 Diabetes: Real-World Exploratory Observation of C-Peptide by Modified Quantitative Response (mQR).

Journal: Diabetes care
Published: January 28, 2026

A Phase 2 Trial of Frexalimab, a CD40L Antagonist, in Adolescents and Adults With Recent-Onset Type 1 Diabetes (FABULINUS): Rationale and Study Design.

A Phase 2 Trial of Frexalimab, a CD40L Antagonist, in Adolescents and Adults With Recent-Onset Type 1 Diabetes (FABULINUS): Rationale and Study Design.

Journal: Diabetes, obesity & metabolism
Published: December 22, 2025

Thyroid autoimmunity and the subsequent development of islet and celiac autoimmunity in the TEDDY study.

Thyroid autoimmunity and the subsequent development of islet and celiac autoimmunity in the TEDDY study.

Journal: American journal of epidemiology
Published: November 06, 2025

Thyroid autoimmunity and the subsequent development of islet and celiac autoimmunity in the TEDDY study.

Thyroid autoimmunity and the subsequent development of islet and celiac autoimmunity in the TEDDY study.

Journal: American journal of epidemiology
Published: November 06, 2025

Everyone or Just Some? Cost-Effectiveness of General Population Versus Targeted Screening Strategies for Type 1 Diabetes in Canada.

Everyone or Just Some? Cost-Effectiveness of General Population Versus Targeted Screening Strategies for Type 1 Diabetes in Canada.

Journal: Diabetes care
Published: September 11, 2025

Phase I Clinical Trial of Islet Antigen-Specific Plasmid Coexpressing Tolerogenic Proteins Demonstrates Safety in Adults With Type 1 Diabetes.

Phase I Clinical Trial of Islet Antigen-Specific Plasmid Coexpressing Tolerogenic Proteins Demonstrates Safety in Adults With Type 1 Diabetes.

Journal: Diabetes
Published: August 19, 2025

Autoimmune Thyroid Disease in a Cohort of Children With Increased Genetic Susceptibility to Type 1 Diabetes: The Environmental Determinants of Diabetes in the Young Study.

Autoimmune Thyroid Disease in a Cohort of Children With Increased Genetic Susceptibility to Type 1 Diabetes: The Environmental Determinants of Diabetes in the Young Study.

Journal: Clinical endocrinology
Published: August 19, 2025

INHALE-1: A Multicenter Randomized Trial of Inhaled Technosphere Insulin in Children With Type 1 Diabetes.

INHALE-1: A Multicenter Randomized Trial of Inhaled Technosphere Insulin in Children With Type 1 Diabetes.

Journal: Diabetes care
Published: August 13, 2025
Showing 1-12 of 197

Last Updated: 09/26/2026